Inhaled Treprostinil in Group 3 Pulmonary Hypertension. Reply

Affiliations

Comment

Steven D Nathan et al. N Engl J Med. 2021.

. 2021 May 13;384(19):1871-1872.

doi: 10.1056/NEJMc2103465.

No abstract available

Comment on

Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
Nasser M, Kolb M, Cottin V. Nasser M, et al. N Engl J Med. 2021 May 13;384(19):1869. doi: 10.1056/NEJMc2103465. N Engl J Med. 2021. PMID: 33979496 No abstract available.
Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
Soto FJ, Kravitz JN, Dhand R. Soto FJ, et al. N Engl J Med. 2021 May 13;384(19):1869-1870. doi: 10.1056/NEJMc2103465. N Engl J Med. 2021. PMID: 33979497 No abstract available.
Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
Saggar R, Abtin F, Channick R. Saggar R, et al. N Engl J Med. 2021 May 13;384(19):1870. doi: 10.1056/NEJMc2103465. N Engl J Med. 2021. PMID: 33979498 No abstract available.
Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
Moran-Mendoza O, Min B, Neder JA. Moran-Mendoza O, et al. N Engl J Med. 2021 May 13;384(19):1870-1871. doi: 10.1056/NEJMc2103465. N Engl J Med. 2021. PMID: 33979499 No abstract available.
Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
Avdeev S, Tsareva N, Nekludova G. Avdeev S, et al. N Engl J Med. 2021 May 13;384(19):1871. doi: 10.1056/NEJMc2103465. N Engl J Med. 2021. PMID: 33979500 No abstract available.